Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pain, Postoperative 19Breast Neoplasms 16Pain 8Agnosia 8Lung Neoplasms 6Prostatic Neoplasms 5Neoplasms 5Stomach Neoplasms 4Colorectal Neoplasms 4Colonic Neoplasms 3Supratentorial Neoplasms 2Postoperative Complications 2Meningioma 2Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Sleep Deprivation 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Pancreatic Ductal Adenocarcinoma 1Pain, Intractable 1Ovarian Cysts 1Oropharyngeal Neoplasms 1Neuroblastoma 1Neoplasm Metastasis 1Malignant Neoplasms of Male Genital Organs 1Liver Neoplasms 1Liver Diseases 1Leiomyoma 1Kidney Neoplasms 1Intraoperative Complications 1

Interventions

Nivolumab 143pembrolizumab 129Sunitinib 127Bevacizumab 71Everolimus 70Sorafenib 68cabozantinib 64Ipilimumab 61pazopanib 58Axitinib 57aldesleukin 51Magnetic Resonance Spectroscopy 43Cyclophosphamide 40Interleukin-2 38lenvatinib 36Radiosurgery 36Specimen Handling 33Interferon-alpha 32atezolizumab 29belzutifan 24temsirolimus 23Gemcitabine 23fludarabine phosphate 22Radiotherapy 18Interferon alpha-2 18Biopsy 18fludarabine 17durvalumab 17avelumab 17Paclitaxel 16

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Carcinoma, Renal Cell × Ropivacaine × Clear all
NCT07092566 2026-01-20

R.E.C.K vs Exparel in Robotic Nephrectomy

Wake Forest University Health Sciences

Phase 3 Recruiting
170 enrolled
Genitourinary

Agnosia, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡